The offering measures AI's real-world performance and safety around handling realistic medical conversations, using physician-created rubrics and GPT-4.1 scoring.
Users implanted with Synchron’s BCI will be able to control iPhone, iPad and Apple Vision Pro with their thoughts without physical movement or voice commands.
The company uses AI and ML to assist biopharma companies with clinical trials and will use the funds to expand its precision medicine and clinical development tools.
The grant will help Verily generate a detailed molecular dataset of Parkinson’s disease, integrating genomic, metabolic, immunologic and digital health data.